Stock UNVO UNIVO PHARMACEUTICALS LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE

Equities

UNVO

IL0010935588

Biotechnology & Medical Research

Business Summary

D-Pharm Ltd. is an Israel-based drug-development company. The Company is focused on developing drugs for the treatment of central nervous system (CNS) conditions. Its area of interest is in developing medicine for degenerative and age-related disorders. The Company’s product portfolio includes three clinical Phase II drug-candidates: THR-18 for thrombolysis, to restore blood flow to the brain, heart or lungs, which completed clinical Phase I and Phase II study in acute stroke patients receiving tPA; DP-VPA for the treatment of epilepsy, migraine and manic depression, which has completed a Phase II study in patients with complex partial epilepsy, and DP-b99, which contains calcium, zinc and copper ions and is used for the protection of cells under stress in acute pancreatitis. The Company’s two technology platforms Membrane Activated Chelator and Regulated Activation of Prodrug use lipid moieties conjugated onto actives such as metal ion chelators or drugs for site specific activation.

Sales per Business

ILS in Million2020Weight2021Weight Delta
Medical Cannabis
89.4 %
19 57.3 % 38 89.4 % +95.57%
Cannabis Product Manufacturing Services
7.7 %
5 15.0 % 3 7.7 % -35.48%
Marketing and Distribution Commissions
2.1 %
1 2.5 % 1 2.1 % +5.04%
Laboratory Services
0.6 %
8 25.1 % 0 0.6 % -96.79%
Other Income
0.1 %
- - 0 0.1 % -

Sales per region

ILS in Million2020Weight2021Weight Delta
Israel
100.0 %
34 100.0 % 42 100.0 % +25.38%

Managers

Managers TitleAgeSince
Golan Bitton CEO
 Chief Executive Officer 47 93-04-03
Jonathan Eilat IRC
 Investor Relations Contact - -
Noam Frakash AUD
 Comptroller/Controller/Auditor 41 21-12-31

Members of the board

Members of the board TitleAgeSince
Chaim Hurvitz CHM
 Chairman 63 19-07-14
Golan Bitton CEO
 Chief Executive Officer 47 93-04-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,293 1,952 ( 59.28 %) 0 59.28 %

Shareholders

NameEquities%Valuation
Excellence Nessuah Mutual Funds Management Ltd.
0.000000 %
0 0.000000 % - ₪
Ramco Mutual Funds Management (1989) Ltd.
0.000000 %
0 0.000000 % - ₪
IBI Mutual Funds Management (1978) Ltd.
0.000000 %
0 0.000000 % - ₪

Company contact information

Univo Pharmaceuticals Ltd.

20 HaHarash Street

7878320, Ashkelon

+

address Univo Pharmaceuticals Ltd(UNVO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+4.09% 43.84B
LONZA GROUP AG Stock Lonza Group AG
+46.73% 41.25B
MODERNA, INC. Stock Moderna, Inc.
+9.45% 41.68B
CELLTRION, INC. Stock Celltrion, Inc.
-10.92% 27.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.32% 25.53B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.87% 18.18B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.70% 12.29B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
+1.28% 12.29B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.78% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. UNVO-M Stock
  4. UNVO Stock
  5. Company Univo Pharmaceuticals Ltd